4 assets in Lymphoid System Disorder

Therapeutic assets addressing Lymphoid System Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclophosphamide Lymphoid System Disorder	M.D. Anderson Cancer Center	P1	CC (43)
Fludarabine Lymphoid System Disorder	M.D. Anderson Cancer Center	P1	CC (43)
il-15 enhanced engineered nk cells Lymphoid System Disorder	M.D. Anderson Cancer Center	P1	CC (43)
Tgfbr2 Ko Car27/Il-15 Nk Cells Lymphoid System Disorder	M.D. Anderson Cancer Center	P1	CC (43)